by webmaster | Mar 17, 2025 | Policy & Regulation, Uncategorized
Position: Today’s regulatory science supports the development of biosimilars based on analytical (physicochemical and functional) data and a clinical pharmacokinetic study (which includes safety and immunogenicity data) alone. Clinical comparative efficacy studies...
by webmaster | Sep 24, 2014 | News, Uncategorized
Duis est enim, feugiat sit amet sollicitudin ut, mattis interdum quam. Ut euismod libero nec orci vulputate lobortis. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Phasellus sit amet nisi at tortor lacinia sodales....
by webmaster | Sep 22, 2014 | News, Uncategorized
[vc_row title_header=”Classic Grid Collection” title_subheader=”photos are cropped, click to open full size in a lightbox” title_style=”fancy” background=”light_section” parallax=”off”...
by webmaster | Sep 22, 2014 | News, Uncategorized
Duis est enim, feugiat sit amet sollicitudin ut, mattis interdum quam. Ut euismod libero nec orci vulputate lobortis. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Phasellus sit amet nisi at tortor lacinia sodales....
by webmaster | Aug 27, 2014 | News, Uncategorized
Duis est enim, feugiat sit amet sollicitudin ut, mattis interdum quam. Ut euismod libero nec orci vulputate lobortis. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Phasellus sit amet nisi at tortor lacinia sodales....